Newsletter
GET THE BUZZ ON CONTINUING MEDICAL EDUCATION COURSES
New Course Alerts and CME News
The Advancing Science of MS Management: Optimizing DMD Therapy
Rockpointe
The diagnosis and management of multiple sclerosis (MS) continue to evolve with the rapid emergence of new agents, new diagnostic criteria, and the identification of MRI measures and biomarkers capable of improving disease surveillance. Combined with the continued push for earlier diagnosis and initiation of disease-modifying drug therapy (DMD), MS diagnosis and management is becoming increasingly complex. Clinicians face more treatment choices, making the formulation of optimal DMD therapies increasingly difficult. In addition, patient concerns with DMD side effects, treatment preferences, drug costs, and other issues continue to negatively impact patient acceptance of and adherence to DMD treatments.
This program will review the latest research and clinical management information on DMD therapies, diagnostic MRI measures, and biomarkers, in order to provide neurologists and other MS specialists with the knowledge and skills needed to improve the management and outcomes of patients with MS.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Employ newer MRI criteria to improve the early diagnosis of MS
- Select effective DMD therapies earlier in the course of MS
- Describe the mechanisms of action and efficacy and safety profiles of current and emerging DMD therapies in MS
- Develop patient-tailored therapies that optimize adherence, increase effectiveness, and improve individual patient outcomes
- Apply evidence from recent diagnostic and prognostic biomarker studies to improve the monitoring of disease activity and response to DMD therapy in MS
This activity is intended for MS specialists, neurologists, and other health care professionals who manage patients with MS.
Click here to register.
Accreditation
Physicians – This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Nurses – Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Designation Statement
Physicians – The Potomac Center for Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, evaluation, please email contact@rockpointe-pcme.com.
Nurses – This educational activity for 1.25 contact hours is provided by Global Education Group. For information about the nursing accreditation of this program, please contact Global at inquire@globaleducationgroup.com or 303-395-1782.
